56 related articles for article (PubMed ID: 37762032)
1. Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis.
Garcia-Recio S; Hinoue T; Wheeler GL; Kelly BJ; Garrido-Castro AC; Pascual T; De Cubas AA; Xia Y; Felsheim BM; McClure MB; Rajkovic A; Karaesmen E; Smith MA; Fan C; Ericsson PIG; Sanders ME; Creighton CJ; Bowen J; Leraas K; Burns RT; Coppens S; Wheless A; Rezk S; Garrett AL; Parker JS; Foy KK; Shen H; Park BH; Krop I; Anders C; Gastier-Foster J; Rimawi MF; Nanda R; Lin NU; Isaacs C; Marcom PK; Storniolo AM; Couch FJ; Chandran U; Davis M; Silverstein J; Ropelewski A; Liu MC; Hilsenbeck SG; Norton L; Richardson AL; Symmans WF; Wolff AC; Davidson NE; Carey LA; Lee AV; Balko JM; Hoadley KA; Laird PW; Mardis ER; King TA; ; Perou CM
Nat Cancer; 2023 Jan; 4(1):128-147. PubMed ID: 36585450
[TBL] [Abstract][Full Text] [Related]
2. Loss of
Simpson KE; Staikos CA; Watson KL; Moorehead RA
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762032
[TBL] [Abstract][Full Text] [Related]
3. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
[TBL] [Abstract][Full Text] [Related]
4. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
[TBL] [Abstract][Full Text] [Related]
5. Mxra8 is a receptor for multiple arthritogenic alphaviruses.
Zhang R; Kim AS; Fox JM; Nair S; Basore K; Klimstra WB; Rimkunas R; Fong RH; Lin H; Poddar S; Crowe JE; Doranz BJ; Fremont DH; Diamond MS
Nature; 2018 May; 557(7706):570-574. PubMed ID: 29769725
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-200b targets protein kinase Cα and suppresses triple-negative breast cancer metastasis.
Humphries B; Wang Z; Oom AL; Fisher T; Tan D; Cui Y; Jiang Y; Yang C
Carcinogenesis; 2014 Oct; 35(10):2254-63. PubMed ID: 24925028
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of bone morphogenetic proteins in the disease progression and metastasis of breast cancer.
Liu M; Sui L; Fang Z; Jiang WG; Ye L
Front Oncol; 2023; 13():1166955. PubMed ID: 37333824
[TBL] [Abstract][Full Text] [Related]
8. CEBPD is a master transcriptional factor for hypoxia regulated proteins in glioblastoma and augments hypoxia induced invasion through extracellular matrix-integrin mediated EGFR/PI3K pathway.
Mao XG; Xue XY; Lv R; Ji A; Shi TY; Chen XY; Jiang XF; Zhang X
Cell Death Dis; 2023 Apr; 14(4):269. PubMed ID: 37059730
[TBL] [Abstract][Full Text] [Related]
9. The role of integrin family in bone metabolism and tumor bone metastasis.
Mao L; Wang L; Xu J; Zou J
Cell Death Discov; 2023 Apr; 9(1):119. PubMed ID: 37037822
[TBL] [Abstract][Full Text] [Related]
10. MXRA8 is an immune-relative prognostic biomarker associated with metastasis and CD8
Tan L; Fu D; Liu F; Liu J; Zhang Y; Li X; Gao J; Tao K; Wang G; Wang L; Wang Z
Front Oncol; 2022; 12():1094612. PubMed ID: 36703779
[TBL] [Abstract][Full Text] [Related]
11. Elevated Expression of miR-200c/141 in MDA-MB-231 Cells Suppresses
Simpson KE; Watson KL; Moorehead RA
Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456497
[TBL] [Abstract][Full Text] [Related]
12. Identification of the receptor of oncolytic virus M1 as a therapeutic predictor for multiple solid tumors.
Song D; Jia X; Liu X; Hu L; Lin K; Xiao T; Qiao Y; Zhang J; Dan J; Wong C; Hu C; Sai K; Gong S; Sander M; Shen R; Chen X; Xiao X; Chen J; Zhang Y; Wei C; Xiao X; Liang J; Zhang Q; Hu J; Zhu W; Yan G; Lin Y; Cai J
Signal Transduct Target Ther; 2022 Apr; 7(1):100. PubMed ID: 35393389
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
